Liquidia Corporation Common Stock vs PPL Corporation Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.49 (market cap $2.40B), while PPL Corporation Common Stock trades at $34.99 (market cap $26.06B). The key difference: PPL Corporation Common Stock is far larger — about 10.9× Liquidia Corporation Common Stock's market cap, and PPL Corporation Common Stock pays a 3.29% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and PPL Corporation Common Stock for 5 Days on average.
| LQDA | PPL | |
|---|---|---|
Market Cap | $2.40B | $26.06B |
Volume | 2,857,547 | 5,432,693 |
Sector | Health | Utilities |
52-Week High | $91.03 | $39.81 |
52-Week Low | $22.02 | $31.97 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $2.30B | $46.05B |
Dividend Yield | — | 3.29% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PPL Corporation trades at $34.63, up 0.84% with a bullish technical outlook supported by moving averages. The utility company shows solid fundamentals with $9.04B revenue, 13.47% net margin, and consistent earnings beats in recent quarters. Analyst consensus is strongly bullish with a $39.45 price target, representing 14% upside potential from current levels. Recent news highlights PPL's $23B infrastructure investment plan and focus on meeting rising electricity demand through strategic capacity expansion.
PPL presents a compelling investment case with strong analyst support, dividend growth potential, and strategic positioning in the growing utility sector. Key risks include execution challenges from the massive capital expenditure program, regulatory hurdles, and competitive pressures. The stock's current valuation at 20.49 P/E appears reasonable given the company's growth trajectory and defensive characteristics in the utility space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →PPL Corporation is a regulated utility holding company. Through its subsidiaries, it generates, transmits, distributes, and sells electricity and natural gas in Kentucky, Pennsylvania, and Rhode Island.
Read more on PPL →